Delivery Order SPE2DB22D3501-SPE2DB24FVK47

Award Date 4/23/24
Potential Completion Date 4/24/24
Potential Value $2.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FVK47
    Delivery Order

This federal contract award, valued at $2,620.58, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the delivery of OPZELURA 1.5% Cream 60GM, a pharmaceutical product.

The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation.

Amerisourcebergen, as one of the largest pharmaceutical distribution companies globally, leverages its extensive supply chain network to fulfill government contracts for critical medical products. This award is part of the company's ongoing efforts to support the logistical needs of the U.S. military and other federal agencies.

Generated 7/23/24, 10:46 AM